The management of Rh-Isoimmunization.
D000017:ABO Blood-Group System; D000649:Amniocentesis; D000653:Amniotic Fluid / Q000032:analysis; D001787:Blood Group Incompatibility / Q000628:therapy; D001805:Blood Transfusion, Intrauterine; D036861:Delivery, Obstetric; D004487:Edema / Q000209:etiology / Q000628:therapy; D004899:Erythroblastosis, Fetal / Q000235:genetics / Q000517:prevention & control; D005260:Female; D005315:Fetal Diseases / Q000209:etiology / Q000628:therapy; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D007518:Isoantibodies / Q000032:analysis; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D012204:Rh-Hr Blood-Group System; D012306:Risk; D012709:Serum Albumin / Q000032:analysis; D013997:Time Factors
D000017:ABO Blood-Group System; D007518:Isoantibodies; D012204:Rh-Hr Blood-Group System; D012709:Serum Albumin